Incontinence & Intimate Partners: Assessing the Contribution of Treatment
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Baseline Sexual Satisfaction Between Matched Female and Male Partners |
4.2; 4.8 | .16 |
| SECONDARY Change in Overall Sexual Satisfaction Among Females |
-0.5; 0 | .003 sig |
| SECONDARY Change in Overall Sexual Satisfaction Among Healthy Male Partners |
0; 0 | .37 |
Eligibility Criteria
Healthy male partners may volunteer to participate in this study along with their affected female partners. There are no inclusion or exclusion criteria for male partners.
For affected female participants, the following inclusion criteria apply:
- Age ≥ 18 years
- In a relationship with a male partner for at least 3 months
- Not pregnant or planning to become pregnant
- Have a diagnosis of UUI or Mixed Urinary Incontinence (MUI) that is urge predominant based on a 3 day voiding diary
- Are interested in medical management of their symptoms
- Are candidates for solifenacin
- Are able to provide informed consent
- Are able to complete written questionnaires.
For affected female partners, the following exclusion criteria apply:
- Post Voided Residual (PVR) > 200 ml at the initial visit
- History of a significant outflow obstruction
- History of persistent/recurrent Urinary Tract Infection (UTI)
- History of bladder stones
- History of a diagnosis of chronic interstitial cystitis
- History of pelvic irradiation
- Current pelvic malignancy
- Narrow angle glaucoma
- Urinary or gastric retention
- Current use of a tricyclic antidepressant
- A neurologic diagnosis that could affect bladder function
- History of chronic pelvic pain
- Active psychotic disorder
- Male partner does not speak English
- Declines permission for the study team to recruit their male partner for the study
Data sourced from ClinicalTrials.gov (NCT01559389). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.